Medraxa Therapeutics
Heidelberg
About Medraxa Therapeutics
Medraxa Therapeutics focusses to offer therapy for patients with cancer or auto-immune diseases through the Annexin Checkpoint System.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2023)
- Website: medraxa.jimdosite.com
Industries & Categories
Biometrics, Biotechnology, Consulting
Canonical: https://fsome.com/organization/medraxa-therapeutics-2996243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.